Black Diamond Therapeutics Inc
NASDAQ:BDTX
Cash Flow Statement
Cash Flow Statement
Black Diamond Therapeutics Inc
| Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||||||||
| Net Income |
(13)
|
(22)
|
(28)
|
(35)
|
(44)
|
(46)
|
(55)
|
(67)
|
(85)
|
(105)
|
(122)
|
(126)
|
(121)
|
(109)
|
(96)
|
(91)
|
(87)
|
(83)
|
(84)
|
(82)
|
(80)
|
(81)
|
(73)
|
(70)
|
5
|
14
|
21
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
1
|
4
|
5
|
7
|
8
|
8
|
9
|
12
|
13
|
14
|
14
|
13
|
13
|
12
|
11
|
11
|
11
|
10
|
9
|
11
|
11
|
11
|
11
|
7
|
7
|
|
| Other Non-Cash Items |
0
|
6
|
8
|
10
|
12
|
7
|
7
|
10
|
12
|
17
|
19
|
18
|
18
|
17
|
16
|
15
|
15
|
14
|
14
|
12
|
10
|
11
|
10
|
10
|
10
|
7
|
8
|
|
| Change in Working Capital |
(3)
|
(0)
|
1
|
0
|
3
|
1
|
3
|
5
|
8
|
12
|
11
|
7
|
(2)
|
(5)
|
(8)
|
(10)
|
(5)
|
(5)
|
(5)
|
4
|
2
|
1
|
2
|
(3)
|
(3)
|
(4)
|
(9)
|
|
| Cash from Operating Activities |
(15)
N/A
|
(16)
-5%
|
(20)
-21%
|
(25)
-26%
|
(29)
-18%
|
(38)
-29%
|
(44)
-16%
|
(52)
-19%
|
(65)
-25%
|
(77)
-18%
|
(92)
-20%
|
(100)
-9%
|
(104)
-4%
|
(97)
+7%
|
(87)
+10%
|
(85)
+2%
|
(77)
+10%
|
(73)
+5%
|
(75)
-3%
|
(67)
+11%
|
(68)
-2%
|
(68)
-1%
|
(61)
+11%
|
(62)
-2%
|
13
N/A
|
18
+45%
|
21
+17%
|
|
| Investing Cash Flow | ||||||||||||||||||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(2)
|
(3)
|
(3)
|
(2)
|
(1)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Items |
0
|
0
|
(0)
|
0
|
(0)
|
(280)
|
(275)
|
(282)
|
(278)
|
51
|
83
|
133
|
147
|
118
|
95
|
54
|
62
|
59
|
6
|
16
|
(22)
|
(39)
|
1
|
17
|
39
|
(21)
|
(14)
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
+67%
|
(0)
-67%
|
(0)
+60%
|
(0)
+50%
|
(280)
-2 796 400%
|
(275)
+2%
|
(282)
-2%
|
(278)
+1%
|
50
N/A
|
81
+63%
|
131
+62%
|
144
+10%
|
115
-20%
|
94
-18%
|
53
-43%
|
61
+15%
|
59
-4%
|
6
-89%
|
16
+154%
|
(22)
N/A
|
(39)
-74%
|
1
N/A
|
17
+1 262%
|
39
+132%
|
(21)
N/A
|
(14)
+32%
|
|
| Financing Cash Flow | ||||||||||||||||||||||||||||
| Net Issuance of Common Stock |
52
|
52
|
92
|
130
|
343
|
343
|
299
|
215
|
2
|
2
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
72
|
72
|
76
|
98
|
25
|
26
|
22
|
(0)
|
1
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
0
|
(0)
|
(0)
|
(2)
|
0
|
(2)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
52
N/A
|
52
0%
|
92
+75%
|
128
+40%
|
342
+167%
|
342
+0%
|
298
-13%
|
215
-28%
|
2
-99%
|
2
+12%
|
2
-12%
|
1
-53%
|
0
-45%
|
0
-48%
|
0
N/A
|
0
-14%
|
0
-56%
|
0
N/A
|
72
+89 838%
|
72
0%
|
76
+6%
|
98
+29%
|
25
-75%
|
26
+2%
|
22
-14%
|
(0)
N/A
|
1
N/A
|
|
| Change in Cash | ||||||||||||||||||||||||||||
| Net Change in Cash |
37
N/A
|
36
-2%
|
72
+99%
|
103
+43%
|
312
+203%
|
24
-92%
|
(21)
N/A
|
(119)
-458%
|
(342)
-188%
|
(25)
+93%
|
(10)
+62%
|
31
N/A
|
40
+28%
|
18
-54%
|
7
-61%
|
(32)
N/A
|
(15)
+52%
|
(14)
+7%
|
4
N/A
|
22
+486%
|
(14)
N/A
|
(9)
+36%
|
(35)
-283%
|
(20)
+43%
|
74
N/A
|
(2)
N/A
|
8
N/A
|
|
| Free Cash Flow | ||||||||||||||||||||||||||||
| Free Cash Flow |
(15)
N/A
|
(16)
-5%
|
(20)
-21%
|
(25)
-26%
|
(29)
-18%
|
(38)
-30%
|
(44)
-16%
|
(52)
-19%
|
(65)
-25%
|
(78)
-19%
|
(94)
-21%
|
(103)
-9%
|
(107)
-4%
|
(99)
+7%
|
(88)
+12%
|
(85)
+3%
|
(77)
+10%
|
(73)
+5%
|
(75)
-3%
|
(67)
+11%
|
(68)
-2%
|
(68)
-1%
|
(61)
+11%
|
(62)
-2%
|
13
N/A
|
18
+45%
|
21
+17%
|
|